Cargando…

Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort

BACKGROUND AND AIMS: Corticosteroids are effective for the short-term treatment of inflammatory bowel disease (IBD). Long-term use, however, is associated with significant adverse effects. To define the: (1) frequency and duration of corticosteroid use, (2) frequency of escalation to corticosteroid-...

Descripción completa

Detalles Bibliográficos
Autores principales: Waljee, Akbar K., Wiitala, Wyndy L., Govani, Shail, Stidham, Ryan, Saini, Sameer, Hou, Jason, Feagins, Linda A., Khan, Nabeel, Good, Chester B., Vijan, Sandeep, Higgins, Peter D. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918923/
https://www.ncbi.nlm.nih.gov/pubmed/27336296
http://dx.doi.org/10.1371/journal.pone.0158017
_version_ 1782439177128771584
author Waljee, Akbar K.
Wiitala, Wyndy L.
Govani, Shail
Stidham, Ryan
Saini, Sameer
Hou, Jason
Feagins, Linda A.
Khan, Nabeel
Good, Chester B.
Vijan, Sandeep
Higgins, Peter D. R.
author_facet Waljee, Akbar K.
Wiitala, Wyndy L.
Govani, Shail
Stidham, Ryan
Saini, Sameer
Hou, Jason
Feagins, Linda A.
Khan, Nabeel
Good, Chester B.
Vijan, Sandeep
Higgins, Peter D. R.
author_sort Waljee, Akbar K.
collection PubMed
description BACKGROUND AND AIMS: Corticosteroids are effective for the short-term treatment of inflammatory bowel disease (IBD). Long-term use, however, is associated with significant adverse effects. To define the: (1) frequency and duration of corticosteroid use, (2) frequency of escalation to corticosteroid-sparing therapy, (3) rate of complications related to corticosteroid use, (4) rate of appropriate bone density measurements (dual energy X-ray absorptiometry [DEXA] scans), and (5) factors associated with escalation and DEXA scans. METHODS: Retrospective review of Veterans Health Administration (VHA) data from 2002–2010. RESULTS: Of the 30,456 Veterans with IBD, 32% required at least one course of corticosteroids during the study time period, and 17% of the steroid users had a prolonged course. Among these patients, only 26.2% underwent escalation of therapy. Patients visiting a gastroenterology (GI) physician were significantly more likely to receive corticosteroid-sparing medications. Factors associated with corticosteroid-sparing medications included younger age (OR = 0.96 per year,95%CI:0.95, 0.97), male gender (OR = 2.00,95%CI:1.16,3.46), GI visit during the corticosteroid evaluation period (OR = 8.01,95%CI:5.85,10.95) and the use of continuous corticosteroids vs. intermittent corticosteroids (OR = 2.28,95%CI:1.33,3.90). Rates of complications per 1000 person-years after IBD diagnosis were higher among corticosteroid users (venous thromboembolism [VTE] 9.0%; fragility fracture 2.6%; Infections 54.3) than non-corticosteroid users (VTE 4.9%; fragility fracture 1.9%; Infections 26.9). DEXA scan utilization rates among corticosteroid users were only 7.8%. CONCLUSIONS: Prolonged corticosteroid therapy for the treatment of IBD is common and is associated with significant harm to patients. Patients with prolonged use of corticosteroids for IBD should be referred to gastroenterology early and universal efforts to improve the delivery of high quality care should be undertaken.
format Online
Article
Text
id pubmed-4918923
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49189232016-07-08 Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort Waljee, Akbar K. Wiitala, Wyndy L. Govani, Shail Stidham, Ryan Saini, Sameer Hou, Jason Feagins, Linda A. Khan, Nabeel Good, Chester B. Vijan, Sandeep Higgins, Peter D. R. PLoS One Research Article BACKGROUND AND AIMS: Corticosteroids are effective for the short-term treatment of inflammatory bowel disease (IBD). Long-term use, however, is associated with significant adverse effects. To define the: (1) frequency and duration of corticosteroid use, (2) frequency of escalation to corticosteroid-sparing therapy, (3) rate of complications related to corticosteroid use, (4) rate of appropriate bone density measurements (dual energy X-ray absorptiometry [DEXA] scans), and (5) factors associated with escalation and DEXA scans. METHODS: Retrospective review of Veterans Health Administration (VHA) data from 2002–2010. RESULTS: Of the 30,456 Veterans with IBD, 32% required at least one course of corticosteroids during the study time period, and 17% of the steroid users had a prolonged course. Among these patients, only 26.2% underwent escalation of therapy. Patients visiting a gastroenterology (GI) physician were significantly more likely to receive corticosteroid-sparing medications. Factors associated with corticosteroid-sparing medications included younger age (OR = 0.96 per year,95%CI:0.95, 0.97), male gender (OR = 2.00,95%CI:1.16,3.46), GI visit during the corticosteroid evaluation period (OR = 8.01,95%CI:5.85,10.95) and the use of continuous corticosteroids vs. intermittent corticosteroids (OR = 2.28,95%CI:1.33,3.90). Rates of complications per 1000 person-years after IBD diagnosis were higher among corticosteroid users (venous thromboembolism [VTE] 9.0%; fragility fracture 2.6%; Infections 54.3) than non-corticosteroid users (VTE 4.9%; fragility fracture 1.9%; Infections 26.9). DEXA scan utilization rates among corticosteroid users were only 7.8%. CONCLUSIONS: Prolonged corticosteroid therapy for the treatment of IBD is common and is associated with significant harm to patients. Patients with prolonged use of corticosteroids for IBD should be referred to gastroenterology early and universal efforts to improve the delivery of high quality care should be undertaken. Public Library of Science 2016-06-23 /pmc/articles/PMC4918923/ /pubmed/27336296 http://dx.doi.org/10.1371/journal.pone.0158017 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Waljee, Akbar K.
Wiitala, Wyndy L.
Govani, Shail
Stidham, Ryan
Saini, Sameer
Hou, Jason
Feagins, Linda A.
Khan, Nabeel
Good, Chester B.
Vijan, Sandeep
Higgins, Peter D. R.
Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
title Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
title_full Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
title_fullStr Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
title_full_unstemmed Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
title_short Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
title_sort corticosteroid use and complications in a us inflammatory bowel disease cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918923/
https://www.ncbi.nlm.nih.gov/pubmed/27336296
http://dx.doi.org/10.1371/journal.pone.0158017
work_keys_str_mv AT waljeeakbark corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT wiitalawyndyl corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT govanishail corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT stidhamryan corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT sainisameer corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT houjason corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT feaginslindaa corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT khannabeel corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT goodchesterb corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT vijansandeep corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort
AT higginspeterdr corticosteroiduseandcomplicationsinausinflammatoryboweldiseasecohort